COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance
Open Access
- 21 April 2020
- journal article
- editorial
- Published by Elsevier BV in Research and Practice in Thrombosis and Haemostasis
- Vol. 4 (4), 439-445
- https://doi.org/10.1002/rth2.12350
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical ProbabilityNew England Journal of Medicine, 2019
- Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary EmbolismNew England Journal of Medicine, 2019
- Pulmonary embolismNature Reviews Disease Primers, 2018
- Acute Myocardial Infarction after Laboratory-Confirmed Influenza InfectionNew England Journal of Medicine, 2018
- Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort studyThe Lancet, 2017
- 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive SummaryCell Metabolism, 2014
- Guidance for diagnosis and treatment of disseminated intravascular coagulation from harmonization of the recommendations from three guidelinesJournal of Thrombosis and Haemostasis, 2013
- Review: Viral infections and mechanisms of thrombosis and bleedingJournal of Medical Virology, 2012